-
Mashup Score: 1
Acute kidney injury (AKI) in patients with COVID-19 is partly mediated by thromboinflammation. In noncritically ill patients with COVID-19, therapeuti…
Source: www.sciencedirect.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 1
Acute kidney injury (AKI) in patients with COVID-19 is partly mediated by thromboinflammation. In non-critically ill patients with COVID-19, therapeut…
Source: www.sciencedirect.comCategories: Cardiologists1, Latest HeadlinesTweet
-
Mashup Score: 02023 ASH Etavopivat Update [Slides] - Zahra Pakbaz MD MOASC - 9 month(s) ago
2023 ASH Pregnancy Update Slides Etavopivat treatment Low molecular weight heparin versus a standard pregnancy care for women with recurrent miscarriage Okay, so this first abstract let’s talk about low molecular weight heparin versus a standard pregnancy care for women with recurrent miscarriage age and inherited t…
Source: oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 6Please wait whilst we redirect you - 10 month(s) ago
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2023 Elsevier B.V. or its licensors or contributors. ScienceDirect® is a registered trademark of Elsevier B.V.ScienceDirect® is a registered trademark…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Please wait whilst we redirect you - 11 month(s) ago
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2023 Elsevier B.V. or its licensors or contributors. ScienceDirect® is a registered trademark of Elsevier B.V.ScienceDirect® is a registered trademark…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 5Study recommends ending heparin use for women with recurrent miscarriage and inherited thrombophilia - 11 month(s) ago
A medication commonly prescribed to pregnant women with an inheritable blood clotting condition and a history of recurrent miscarriage does not help to reduce their miscarriage risk, a new international study led by UK researchers has found.
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19 - 1 year(s) ago
This exploratory study of a multiplatform randomized trial investigating the effects of therapeutic-dose heparin in early-pandemic hospitalized COVID-19 patients describes findings from 3 statistical approaches to detecting differences of treatment effect in clinically relevant patient subgroups.
Source: jamanetwork.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Aspirin Noninferior to Low-Molecular-Weight Heparin for Preventing Death in Patients with Fractures - 1 year(s) ago
The researchers compared the efficacy of thromboprophylaxis with aspirin to low-molecular-weight heparin in patients with orthopedic trauma.
Source: Consultant360Categories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0A Pilot Study to Assess the Clinical Onset of IV Heparin in Interventional Cardiology and Cardiac Surgery - 1 year(s) ago
To determine the onset of heparin anticoagulation, using 2 different measures of activated clotting times (ACT), thromboelastography (TEG; R-time), and anti-Xa levels, after administering low- (100 U/kg) and high- (300 U/kg) dose intravenous (IV) heparin to patients undergoing transcatheter aortic valve replacement (TAVR) and cardiac surgery, respectively.
Categories: Anesthesiology, Latest HeadlinesTweet
-
Mashup Score: 2vision for a quicker definitive diagnosis of HIT - 1 year(s) ago
In this issue of Blood, Kanack and colleagues1 provide proof-of-concept for a new approach to definitive diagnosis of heparin-induced thrombocytopenia (HIT). Us
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
Effect of #therapeutic-dose #heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for #COVID-19: a prespecified secondary analysis of the #ACTIV4a and #ATTACC randomized trial https://t.co/lBSe4DAEfl https://t.co/W5quUH6Kcj